Buck Institute for Research on Aging
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Buck Institute for Research on Aging sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Buck Institute for Research on Aging: 5 sponsored US clinical trials, 4 recruiting.
Buck Institute for Research on Aging sponsors 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Aging, with 3 trials.
Upper-quartile sponsor footprint
Buck Institute for Research on Aging sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Temporal Investigation of Multimodal Elements
NCT07107386
GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women
NCT06813261
Targeting Aging With a Ketone Ester for Function in Frailty
NCT06645847
Molecular Optimization Via Exercise (MOVE)
NCT06540287
Buck Institute Ketone Ester RCT
NCT05585762
What is open in the Buck Institute for Research on Aging pipeline
4 recruiting of 5 indexed (80% open); 1 completed (20%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Aging (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Buck Institute for Research on Aging: open-pipeline peers nationwide
Peers matched on 5 registered trials and 80% open enrollment, not the therapeutic-area sidebar.
Buck Institute for Research on Aging sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 80% open enrollment (± trial volume)
- Alpha Tau Medical · 80% recruiting · 5 trials
- IDEAYA Biosciences · 80% recruiting · 10 trials
- MapLight Therapeutics · 80% recruiting · 5 trials
- Mirador Therapeutics · 80% recruiting · 5 trials
Related
What to do with this Buck Institute for Research on Aging page
5 registered trials is a research-attention snapshot, not an endorsement of Buck Institute for Research on Aging or any single study.
- 4 of Buck Institute for Research on Aging's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aging is the condition Buck Institute for Research on Aging studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aging trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Buck Institute for Research on Aging pipeline card: 5 registered trials from official public datasets.Report a data error.